Literature DB >> 19024335

Has the HIV epidemic in rural Mwanza, Tanzania reached a plateau?

W Mwita1, J Chilongani, R White, G Mshana, J Changalucha, F Mosha, D Ross, B Zaba, J Todd.   

Abstract

Data from studies in Mwanza Region in Tanzania suggest stabilising HIV prevalence. The objective was to determine the factors that may have contributed to the relatively stable pattern of the HIV prevalence observed in the comparison communities of the Mwanza STD treatment trial in rural Mwanza Region, Tanzania between 1991 and 2001. Socio-demographic, sexual behaviour and HIV prevalence data in two surveys conducted 10 years apart in the same communities using similar sampling schemes were compared. The age standardised HIV prevalence was 3.8% (95% CI: 3.2-4.6) in 1991 and 4.3% (95% CI: 2.8-6.4) in 2001 for males (Z= - 0.56, P= 0.58); and 4.5% (95% CI: 3.8-5.3) in 1991 and 3.9% (95% CI: 2.6-5.6) in 2001 for females (Z= 0.64, P = 0.52). Participants in the 2001 survey reported significantly fewer lifetime and recent sexual partners (12 months), Sexually Transmitted disease syndromes (12 months) and significantly more condom use at last sex with casual partners than those in the 1991 behaviour survey. We conclude that STD/HIV infection prevention activities in rural Mwanza may be responsible for changes in risky sexual behaviour and have successfully impeded the spread of HIV infection. These activities should therefore be enhanced to reduce HIV incidence even further. In addition, modelling studies are needed to assess whether mobility of HIV infected people out of rural communities may stabilise the prevalence of the HIV infection in the general populations.

Entities:  

Mesh:

Year:  2008        PMID: 19024335     DOI: 10.4314/thrb.v10i3.14333

Source DB:  PubMed          Journal:  Tanzan J Health Res        ISSN: 1821-9241


  1 in total

1.  Adjusting the HIV prevalence for non-respondents using mortality rates in an open cohort in northwest Tanzania.

Authors:  Filemon Tenu; Raphael Isingo; Basia Zaba; Mark Urassa; Jim Todd
Journal:  Trop Med Int Health       Date:  2014-03-21       Impact factor: 2.622

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.